Tus kws kho mob
QP61-23 MHCP Pharmacy Benefit Exclusion for Elfabrio®, Epkinly™, and Vyjuvek™
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 12, 2023
Tshawb Nrhiav
Nthuav pom cov txiaj ntsig tshwm sim 1041 - 1050 ntawm 4204
Tus kws kho mob
QP62-23 Commercial Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective September 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 12, 2023
Tus kws kho mob
QP63-23 MHCP Pharmacy Benefit Update: Revised Drug-Related Prior Authorization (PA) Requirement Notification, Effective August 1, 2023
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 12, 2023
Tus kws kho mob
QP64-23 Medical Drug Update for New to Market Valoctocogene Roxaparvovec (Roctavian, f.k.a. Valrox)
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 12, 2023
Cov Ntaub Ntawv Qhia Paub Fab Nyiaj Txiag
Tus kws kho mob
commercial-em-007-critical-care-services.pdf
Tus kws kho mob
upcoming-policies-effective-september-4-2023.pdf
Tus kws kho mob
P47R1-23 MHCP Enrollment for Managed Care Organization (MCO) In-network Only Providers
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 03, 2023
Tus kws kho mob
P48-23 Additional Records Received After Due Date
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 03, 2023
Tus kws kho mob
P49-23 Minnesota Health Care Programs (MHCP) Operations Transition: New ID Numbers for MHCP Members
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 03, 2023
Tus kws kho mob
P50-23 eviCore Healthcare Specialty Utilization Management (UM) Program: Medical Oncology Drug Prior Authorization Updates
Hnub Tim pib siv tau lub khoos kas: Lub Xya Hli Ntuj Tim 03, 2023